NCT01972451View on ClinicalTrials.gov

Feasibility of Reduction in Right Sided Bowel Cancer Through Contrast Enhanced Colonoscopy

PHASE2CompletedINTERVENTIONAL
Enrollment

1,320

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Colorectal Cancer
Interventions
PROCEDURE

Colonoscopy with enhanced dye

Trial Locations (1)

CF14 4YS

Wales Cancer Trials Unit, Cardiff

All Listed Sponsors
lead

Lisette Nixon

OTHER

NCT01972451 - Feasibility of Reduction in Right Sided Bowel Cancer Through Contrast Enhanced Colonoscopy | Biotech Hunter | Biotech Hunter